TABLE 1.
Primer and probe sequences used in the present study
| Name | 5′-3′ sequence |
|---|---|
| ctrA forward 1 | TTGTGTGGAAGTTTAATTGTAGGATGC |
| ctrA reverse 1 | TCAGATTGTTGCCCTAAAGAGACA |
| ctrA TaqMan probe 1 | TCCTTCATCAGGCCCCAGCGa |
| ctrA forward 2 | GCTGCGGTAGGTGGTTCAA |
| ctrA reverse 2 | TTGTCGCGGATTTGCAACTA |
| ctrA TaqMan probe 2 | CATTGCCACGTGTCAGCTGCACATa |
| Group B forward | TGCATGTCCCCTTTCCTGA |
| Group B reverse | AATGGGGTAGCGTTGACTAACAA |
| Group B TaqMan probe | TGCTTATTCCTCCAGCATGCGCAAAa |
| Group C forward | GATAAATTTGATATTTTGCATGTAGCTTTC |
| Group C reverse | TGAGATATGCGGTATTTGTCTTGAAT |
| Group C TaqMan probe | TTGGCTTGTGCTAATCCCGCCTGAa |
a
Labeled with carboxyfluorescein (FAM) at 5′ position and carboxytetramethyl rhodamine (TAMRA) at 3′ position.